(1->4)-beta-D-glucan multiple interactions ISO Ckap2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CKAP2 mRNA CTD PMID:36331819 1,1-dichloroethene increases expression ISO Ckap2 (Mus musculus) 6480464 vinylidene chloride results in increased expression of CKAP2 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CKAP2 mRNA CTD PMID:30723492 17beta-estradiol multiple interactions ISO Ckap2 (Mus musculus) 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of CKAP2 mRNA] CTD PMID:25210133 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKAP2 mRNA CTD PMID:32741896 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of CKAP2 mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO Ckap2 (Mus musculus) 6480464 Estradiol results in increased expression of CKAP2 mRNA CTD PMID:25210133 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKAP2 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Ckap2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Ckap2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ckap2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CKAP2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CKAP2 mRNA CTD PMID:32109520 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ckap2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CKAP2 mRNA CTD PMID:26377647 2,4-diaminotoluene increases expression ISO Ckap2 (Mus musculus) 6480464 2 and 4-diaminotoluene results in increased expression of CKAP2 mRNA CTD PMID:20713471 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of CKAP2 mRNA CTD PMID:17109745 2-methylcholine affects expression ISO CKAP2 (Homo sapiens) 6480464 beta-methylcholine affects the expression of CKAP2 mRNA CTD PMID:21179406 2-palmitoylglycerol increases expression ISO CKAP2 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of CKAP2 mRNA CTD PMID:37199045 3-methylcholanthrene increases expression ISO Ckap2 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of CKAP2 mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide increases expression ISO Ckap2 (Mus musculus) 6480464 Fenretinide results in increased expression of CKAP2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CKAP2 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression ISO Ckap2 (Mus musculus) 6480464 9 more ... CTD PMID:32553695 acetamide increases expression EXP 6480464 acetamide results in increased expression of CKAP2 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of CKAP2 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO CKAP2 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of CKAP2 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO CKAP2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of CKAP2 exon CTD PMID:30157460 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CKAP2 mRNA CTD PMID:23630614 more ... Aflatoxin B2 alpha decreases methylation ISO CKAP2 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of CKAP2 exon CTD PMID:30157460 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of CKAP2 mRNA CTD PMID:17109745 aldehydo-D-glucose multiple interactions ISO Ckap2 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA CTD PMID:37567420 all-trans-retinoic acid decreases expression ISO CKAP2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of CKAP2 mRNA CTD PMID:33167477 antirheumatic drug decreases expression ISO CKAP2 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of CKAP2 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO CKAP2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of CKAP2 protein CTD PMID:33212167 arsenous acid multiple interactions ISO Ckap2 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CKAP2 mRNA] CTD PMID:29095437 arsenous acid increases expression ISO Ckap2 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of CKAP2 mRNA CTD PMID:29095437 azathioprine decreases expression ISO CKAP2 (Homo sapiens) 6480464 Azathioprine results in decreased expression of CKAP2 mRNA CTD PMID:22623647 benzo[a]pyrene increases expression ISO Ckap2 (Mus musculus) 6480464 Benzo(a)pyrene metabolite results in increased expression of CKAP2 mRNA and Benzo(a)pyrene results in increased expression of CKAP2 mRNA CTD PMID:19770486 more ... benzo[a]pyrene affects methylation ISO CKAP2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CKAP2 exon CTD PMID:30157460 benzo[a]pyrene multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA CTD PMID:27858113 benzo[a]pyrene diol epoxide I decreases expression ISO CKAP2 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO Ckap2 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of CKAP2 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA CTD PMID:27858113 benzo[e]pyrene decreases methylation ISO CKAP2 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of CKAP2 exon CTD PMID:30157460 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of CKAP2 mRNA CTD PMID:17109745 bisphenol A affects expression ISO CKAP2 (Homo sapiens) 6480464 bisphenol A affects the expression of CKAP2 mRNA CTD PMID:19490990 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CKAP2 mRNA CTD PMID:32145629 and PMID:34947998 bisphenol A decreases expression ISO CKAP2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of CKAP2 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CKAP2 gene CTD PMID:28505145 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CKAP2 mRNA CTD PMID:25181051 buta-1,3-diene increases expression ISO Ckap2 (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of CKAP2 mRNA CTD PMID:29038090 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CKAP2 mRNA CTD PMID:25993096 caffeine decreases phosphorylation ISO CKAP2 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of CKAP2 protein CTD PMID:35688186 calcitriol decreases expression ISO CKAP2 (Homo sapiens) 6480464 Calcitriol results in decreased expression of CKAP2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO CKAP2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CKAP2 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO Ckap2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25926378 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of CKAP2 mRNA CTD PMID:18500788 choline multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CKAP2 mRNA CTD PMID:20938992 chrysene multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA CTD PMID:27858113 cisplatin increases expression ISO Ckap2 (Mus musculus) 6480464 Cisplatin results in increased expression of CKAP2 mRNA CTD PMID:21151649 clofibrate multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CKAP2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CKAP2 mRNA] CTD PMID:17585979 copper atom increases expression EXP 6480464 Copper results in increased expression of CKAP2 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of CKAP2 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO CKAP2 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of CKAP2 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO CKAP2 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CKAP2 mRNA CTD PMID:19167446 CU-O LINKAGE decreases expression ISO CKAP2 (Homo sapiens) 6480464 cupric oxide results in decreased expression of CKAP2 mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CKAP2 mRNA CTD PMID:26577399 and PMID:27523638 cyclosporin A decreases expression ISO CKAP2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CKAP2 mRNA CTD PMID:20106945 more ... D-glucose multiple interactions ISO Ckap2 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA CTD PMID:37567420 deoxynivalenol increases expression ISO CKAP2 (Homo sapiens) 6480464 deoxynivalenol results in increased expression of CKAP2 mRNA CTD PMID:31863870 diallyl trisulfide decreases expression ISO CKAP2 (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of CKAP2 mRNA CTD PMID:34995734 diarsenic trioxide multiple interactions ISO Ckap2 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CKAP2 mRNA] CTD PMID:29095437 diarsenic trioxide increases expression ISO Ckap2 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of CKAP2 mRNA CTD PMID:29095437 dibenz[a,h]anthracene increases expression ISO Ckap2 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO Ckap2 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of CKAP2 mRNA CTD PMID:17361019 and PMID:21266533 dichloroacetic acid increases expression ISO Ckap2 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of CKAP2 mRNA CTD PMID:28962523 dicrotophos decreases expression ISO CKAP2 (Homo sapiens) 6480464 dicrotophos results in decreased expression of CKAP2 mRNA CTD PMID:28302478 dioxygen multiple interactions ISO Ckap2 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CKAP2 mRNA CTD PMID:30529165 diquat decreases expression ISO Ckap2 (Mus musculus) 6480464 Diquat results in decreased expression of CKAP2 mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO CKAP2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO CKAP2 (Homo sapiens) 6480464 CKAP2 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression ISO CKAP2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of CKAP2 mRNA CTD PMID:29803840 Echimidine increases expression EXP 6480464 echimidine results in increased expression of CKAP2 mRNA CTD PMID:32419051 elemental selenium decreases expression ISO CKAP2 (Homo sapiens) 6480464 Selenium results in decreased expression of CKAP2 mRNA CTD PMID:19244175 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CKAP2 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO CKAP2 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CKAP2 protein CTD PMID:23301498 ethyl methanesulfonate increases expression ISO CKAP2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of CKAP2 mRNA CTD PMID:23649840 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CKAP2 mRNA CTD PMID:24793618 folic acid multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CKAP2 mRNA CTD PMID:20938992 FR900359 increases phosphorylation ISO CKAP2 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of CKAP2 protein CTD PMID:37730182 fructose multiple interactions ISO Ckap2 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA CTD PMID:37567420 furan increases expression EXP 6480464 furan results in increased expression of CKAP2 mRNA CTD PMID:25539665 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CKAP2 mRNA CTD PMID:33387578 glucose multiple interactions ISO Ckap2 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA CTD PMID:37567420 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of CKAP2 mRNA CTD PMID:24395379 and PMID:24915197 glyphosate multiple interactions ISO Ckap2 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA CTD PMID:37567420 Heliotrine increases expression EXP 6480464 heliotrine results in increased expression of CKAP2 mRNA CTD PMID:32419051 hydrogen peroxide affects expression ISO CKAP2 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of CKAP2 mRNA CTD PMID:21179406 L-methionine multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CKAP2 mRNA CTD PMID:20938992 leflunomide decreases expression ISO CKAP2 (Homo sapiens) 6480464 leflunomide results in decreased expression of CKAP2 mRNA CTD PMID:28988120 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of CKAP2 mRNA CTD PMID:35283115 metformin multiple interactions ISO Ckap2 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CKAP2 mRNA] CTD PMID:29095437 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of CKAP2 mRNA CTD PMID:28341135 methapyrilene decreases methylation ISO CKAP2 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of CKAP2 exon CTD PMID:30157460 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CKAP2 mRNA CTD PMID:30467583 methyl methanesulfonate increases expression ISO CKAP2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of CKAP2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO CKAP2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of CKAP2 mRNA CTD PMID:28001369 mitomycin C increases expression ISO Ckap2 (Mus musculus) 6480464 Mitomycin results in increased expression of CKAP2 mRNA CTD PMID:25270620 N-nitrosodiethylamine multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CKAP2 mRNA and RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CKAP2 mRNA] CTD PMID:17854601 and PMID:24535843 N-nitrosodiethylamine increases expression ISO Ckap2 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CKAP2 mRNA CTD PMID:17854601 and PMID:24535843 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CKAP2 mRNA CTD PMID:25729387 ozone decreases expression ISO Ckap2 (Mus musculus) 6480464 Ozone results in decreased expression of CKAP2 mRNA CTD PMID:24336422 ozone multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CKAP2 mRNA more ... CTD PMID:25658374 more ... paracetamol multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CKAP2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CKAP2 mRNA] CTD PMID:17585979 paracetamol increases expression ISO CKAP2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of CKAP2 mRNA CTD PMID:22230336 PCB138 multiple interactions ISO Ckap2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 perfluorooctane-1-sulfonic acid multiple interactions ISO Ckap2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CKAP2 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CKAP2 mRNA CTD PMID:36331819 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of CKAP2 mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CKAP2 mRNA and NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CKAP2 mRNA] CTD PMID:19482888 and PMID:24535843 phenobarbital increases expression ISO Ckap2 (Mus musculus) 6480464 Phenobarbital results in increased expression of CKAP2 mRNA CTD PMID:19482888 and PMID:23091169 phenylmercury acetate decreases expression ISO CKAP2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of CKAP2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO CKAP2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CKAP2 mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of CKAP2 mRNA CTD PMID:29877212 pirinixic acid multiple interactions ISO CKAP2 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CKAP2 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO Ckap2 (Mus musculus) 6480464 pirinixic acid results in increased expression of CKAP2 mRNA CTD PMID:18301758 and PMID:23811191 pirinixic acid decreases expression ISO Ckap2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of CKAP2 mRNA CTD PMID:20813756 progesterone decreases expression ISO CKAP2 (Homo sapiens) 6480464 Progesterone results in decreased expression of CKAP2 mRNA CTD PMID:21795739 resveratrol multiple interactions ISO CKAP2 (Homo sapiens) 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of CKAP2 mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of CKAP2 mRNA CTD PMID:19167446 and PMID:23557933 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of CKAP2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO CKAP2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom decreases expression ISO CKAP2 (Homo sapiens) 6480464 Selenium results in decreased expression of CKAP2 mRNA CTD PMID:19244175 senecionine increases expression EXP 6480464 senecionine results in increased expression of CKAP2 mRNA CTD PMID:32419051 Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of CKAP2 mRNA CTD PMID:32419051 serpentine asbestos multiple interactions ISO Ckap2 (Mus musculus) 6480464 SPP1 gene mutant form inhibits the reaction [Asbestos and Serpentine results in increased expression of CKAP2 mRNA] CTD PMID:21514415 serpentine asbestos increases expression ISO Ckap2 (Mus musculus) 6480464 Asbestos and Serpentine results in increased expression of CKAP2 mRNA CTD PMID:21514415 silicon dioxide increases expression ISO Ckap2 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of CKAP2 mRNA CTD PMID:29341224 silver atom decreases expression ISO Ckap2 (Mus musculus) 6480464 Silver results in decreased expression of CKAP2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Ckap2 (Mus musculus) 6480464 Silver results in decreased expression of CKAP2 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO Ckap2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of CKAP2 mRNA CTD PMID:17998272 sodium arsenite increases expression ISO CKAP2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CKAP2 mRNA CTD PMID:29301061 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of CKAP2 mRNA CTD PMID:22110744 sodium fluoride decreases expression ISO Ckap2 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of CKAP2 protein CTD PMID:28918527 sunitinib decreases expression ISO CKAP2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of CKAP2 mRNA CTD PMID:31533062 tacrolimus hydrate increases expression ISO Ckap2 (Mus musculus) 6480464 Tacrolimus results in increased expression of CKAP2 mRNA CTD PMID:29362864 testosterone multiple interactions ISO CKAP2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CKAP2 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKAP2 mRNA CTD PMID:32741896 testosterone decreases expression ISO CKAP2 (Homo sapiens) 6480464 Testosterone results in decreased expression of CKAP2 mRNA CTD PMID:21592394 testosterone enanthate affects expression ISO CKAP2 (Homo sapiens) 6480464 testosterone enanthate affects the expression of CKAP2 mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO Ckap2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CKAP2 mRNA CTD PMID:17484886 more ... tetraphene multiple interactions ISO Ckap2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA CTD PMID:27858113 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CKAP2 mRNA CTD PMID:23411599 and PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CKAP2 mRNA CTD PMID:30012374 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of CKAP2 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CKAP2 mRNA CTD PMID:25729387 topotecan affects response to substance ISO CKAP2 (Homo sapiens) 6480464 CKAP2 protein affects the susceptibility to Topotecan CTD PMID:16217747 trimellitic anhydride increases expression ISO Ckap2 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of CKAP2 mRNA CTD PMID:19042947 Triptolide increases expression ISO Ckap2 (Mus musculus) 6480464 triptolide results in increased expression of CKAP2 mRNA CTD PMID:32835833 trovafloxacin decreases expression ISO Ckap2 (Mus musculus) 6480464 trovafloxacin results in decreased expression of CKAP2 mRNA CTD PMID:35537566 valproic acid decreases expression ISO CKAP2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CKAP2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO CKAP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CKAP2 mRNA CTD PMID:27188386 vincaleukoblastine affects response to substance ISO CKAP2 (Homo sapiens) 6480464 CKAP2 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vitamin E decreases expression ISO CKAP2 (Homo sapiens) 6480464 Vitamin E results in decreased expression of CKAP2 mRNA CTD PMID:19244175